Impact of Protease Inhibitor–Based Anti‐Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients
暂无分享,去创建一个
D. Segev | P. MacLennan | S. Gustafson | R. Reed | J. Locke | D. Sawinski | S. Mehta | B. Shelton | Paul A. MacLennan
[1] R. Formica,et al. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation , 2017, International journal of STD & AIDS.
[2] J. Camargo,et al. Antiretroviral Therapy Combo Pills in HIV+ Kidney Transplant Recipients: First Do No Harm , 2017, The Annals of Pharmacotherapy.
[3] J. Figueiró,et al. Impact of antiretroviral therapy on clinical outcomes in HIV + kidney transplant recipients: Review of 58 cases , 2016, F1000Research.
[4] H. Monsour,et al. Combination Drug Products for HIV—A Word of Caution for the Transplant Clinician , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] Aasld Idsa Hcv Guidance Panel. Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus , 2015, Hepatology.
[6] D. Segev,et al. A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients. , 2015, Journal of the American Society of Nephrology : JASN.
[7] Kevin C. Eddinger,et al. Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients , 2015, Kidney international.
[8] J. Phair,et al. Effect of HCV, HIV and Coinfection in Kidney Transplant Recipients: Mate Kidney Analyses , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] S. Khoo,et al. Kidney transplantation in HIV-positive adults: the UK experience , 2014, International journal of STD & AIDS.
[10] F. Burgos,et al. Renal transplantation in HIV-infected patients: experience at a tertiary hospital in Spain and review of the literature. , 2013, Transplantation proceedings.
[11] A. V. van Zuilen,et al. Pretransplantation Pharmacokinetic Curves of Tacrolimus in HIV-Infected Patients on Ritonavir-Containing cART: A Pilot Study , 2013, Transplantation.
[12] R. Jindal,et al. High Frequency of Rejections in HIV-Positive Recipients of Kidney Transplantation: A Single Center Prospective Trial , 2012, Transplantation.
[13] A. V. van Zuilen,et al. Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: a review. , 2012, AIDS patient care and STDs.
[14] A. Jardine,et al. Prevention of cardiovascular disease in adult recipients of kidney transplants , 2011, The Lancet.
[15] D. Stablein,et al. Outcomes of kidney transplantation in HIV-infected recipients. , 2010, The New England journal of medicine.
[16] M. Delahousse,et al. Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] Lynne Peeples,et al. Class-sparing regimens for initial treatment of HIV-1 infection. , 2008, The New England journal of medicine.
[18] L. Benet,et al. Immunosuppressant Pharmacokinetics and Dosing Modifications in HIV‐1 Infected Liver and Kidney Transplant Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] O. Kirk,et al. Class of antiretroviral drugs and the risk of myocardial infarction. , 2007, The New England journal of medicine.
[20] M. Moritz,et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. , 2005, Kidney international.
[21] O. Kirk,et al. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? , 2004, The Journal of infectious diseases.
[22] T. Starzl,et al. Clinical Pharmacokinetics of Tacrolimus , 1995, Clinical pharmacokinetics.
[23] Mario Prost. System , 2019, Concepts for International Law.
[24] B. Murphyc,et al. HIV-Infected Liver and Kidney Transplant Recipients : 1-and 3-Year Outcomes , 2007 .
[25] J. Eastone,et al. New-onset diabetes mellitus associated with use of protease inhibitor. , 1997, Annals of internal medicine.
[26] D. Ivanovski,et al. Printed in U.SA , 1988 .